LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 29c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.02), $0.29 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.99 million.

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• Li Auto Inc. (LI) Misses Q2 EPS by 2c; misses on guidance
• Kohl's (KSS) Tops Q2 EPS by 71c; raises guidance